[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Nuvana Healthcare LTD\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":44},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":5},"100604037",false,"NCT07144306","AI-Driven Early Detection of Skin Cancer","Skin Cancer","Inclusion Criteria:\n\nAdults (≥18 years) presenting with skin lesions suspicious for malignancy.\n\nAbility to provide informed consent.\n\nExclusion Criteria:\n\nInability to provide informed consent.\n\nPoor-quality images unsuitable for AI analysis.",true,"ALL","18 Months",{"count":19,"type":20},100,"ESTIMATED","50 Months","OBSERVATIONAL","This study evaluates the feasibility and accuracy of an AI-powered mobile platform (NuvanaDx) for early detection of skin cancer, including melanoma, using smartphone-based imaging. The platform is designed to improve access to early diagnosis, reduce waiting times, and support triage into appropriate care pathways.",[25],"Skin Cancer Melanoma",[13,27,28,29,30,31],"Melanoma","Early Detection","Artificial Intelligence","Dermatology","Digital Health","RECRUITING","2025-09-25",{"date":35,"type":36},"2025-09-26","ACTUAL",{"date":38,"type":20},"2025-10-01",{"date":40,"type":20},"2026-01-01",{"name":42,"class":43},"Nuvana Healthcare LTD","INDUSTRY",""]